Trials / Recruiting
RecruitingNCT06557317
In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes
Examining the Preliminary Efficacy of an In-Person Lifestyle Intervention for Black Female Adolescent/Caregiver Dyads at Risk for Type 2 Diabetes Mellitus
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Cornell University · Academic / Other
- Sex
- Female
- Age
- 12 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to look at changes in diabetes-related risk factors in Black adolescent girls who are at risk for type 2 diabetes and their primary female caregiver after both participating in a 12-week in-person lifestyle program.
Detailed description
Enrolled adolescent/caregiver dyads will participate in the 12-week program. Each week, participants will engage in 2 activities: an in-person Wellness Session and an at-home cooking experience using ingredients provided at the Wellness Session. The study will examine the pre-post difference in overall diet quality, dermal carotenoid levels, physical activity, body composition, and glycemic measures among at-risk black adolescent girls and their caregivers. Investigators hypothesize that after the program, participants' diets will be higher in quality than before.
Conditions
- Behavior, Adolescent
- Childhood Obesity
- Diabetes Mellitus, Type 2
- Pediatric Obesity
- Glucose Metabolism Disorders
- Metabolic Disease
- Endocrine System Diseases
- Overweight
- Overnutrition
- Nutrition Disorders
- Body Weight
- Diabetes Mellitus
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Black Girls for Wellness In-Person | Weekly for 12 weeks, adolescent/caregiver dyads will attend 1) an in-person Wellness Session (mindfulness, nutrition lesson, dance class, program reflection) (90 min/wk) and 2) a home cooking experience using ingredients provided at the Wellness Session (60 min/wk). |
Timeline
- Start date
- 2024-08-01
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2024-08-16
- Last updated
- 2024-08-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06557317. Inclusion in this directory is not an endorsement.